Background: Children with nonclassical congenital adrenal hyperplasia (NCCAH) often present increased growth velocity secondary to elevation of adrenal androgens that accelerates bone maturation and might compromise adult height (AH). Objective: The aim of the study was to analyze prognostic factors affecting growth trajectory (GT) and AH in children with NCCAH. Methods: The study was a retrospective, multicentric study. The study population consisted of 192 children with a confirmed molecular diagnosis of NCCAH, followed by pediatric endocrinology centers from diagnosis up to AH. Clinical records were collected and analyzed. AH (standard deviation score; SDS), pubertal growth (PG) (cm), GT from diagnosis to AH (SDS), and AH adjusted to target height (TH) (AH-TH SDS) were evaluated as outcome indicators using stepwise linear regression models. Results: The stepwise linear regression analysis showed that AH and AH-TH were significantly related to chronological age (CA) (p = 0.008 and 0.016), bone age (BA)/CA ratio (p = 0.004 and 0.001), height (H) (p < 0.001 for both parameters) at NCCAH diagnosis, and TH (p = 0.013 and <0.001). PG was higher in males than in females (22.59 ± 5.74 vs. 20.72 ± 17.4 cm, p = 0.002), as physiologically observed, and was positively related to height (p = 0.027), negatively to BMI (p = 0.001) and BA/CA ratio (p = 0.001) at NCCAH diagnosis. Gender, genotype, biochemical data, and hydrocortisone treatment did not significantly impair height outcomes of these NCCAH children. Conclusions: The results of this study suggest that AH and GT of NCCAH patients are mainly affected by the severity of phenotype (CA, BA/CA ratio, and H) at the time of diagnosis.

Growth Trajectory and Adult Height in Children with Nonclassical Congenital Adrenal Hyperplasia / Wasniewska, M. G.; Morabito, L. A.; Baronio, F.; Einaudi, S.; Salerno, M.; Bizzarri, C.; Russo, G.; Chiarito, M.; Grandone, A.; Guazzarotti, L.; Spinuzza, A.; Corica, D.; Ortolano, R.; Balsamo, A.; Abrigo, E.; Baldini Ferroli, B.; Alibrandi, A.; Capalbo, D.; Aversa, T.; Faienza, M. F.. - In: HORMONE RESEARCH IN PAEDIATRICS. - ISSN 1663-2818. - 93:3(2020), pp. 173-181. [10.1159/000509548]

Growth Trajectory and Adult Height in Children with Nonclassical Congenital Adrenal Hyperplasia

Salerno M.;Capalbo D.;
2020

Abstract

Background: Children with nonclassical congenital adrenal hyperplasia (NCCAH) often present increased growth velocity secondary to elevation of adrenal androgens that accelerates bone maturation and might compromise adult height (AH). Objective: The aim of the study was to analyze prognostic factors affecting growth trajectory (GT) and AH in children with NCCAH. Methods: The study was a retrospective, multicentric study. The study population consisted of 192 children with a confirmed molecular diagnosis of NCCAH, followed by pediatric endocrinology centers from diagnosis up to AH. Clinical records were collected and analyzed. AH (standard deviation score; SDS), pubertal growth (PG) (cm), GT from diagnosis to AH (SDS), and AH adjusted to target height (TH) (AH-TH SDS) were evaluated as outcome indicators using stepwise linear regression models. Results: The stepwise linear regression analysis showed that AH and AH-TH were significantly related to chronological age (CA) (p = 0.008 and 0.016), bone age (BA)/CA ratio (p = 0.004 and 0.001), height (H) (p < 0.001 for both parameters) at NCCAH diagnosis, and TH (p = 0.013 and <0.001). PG was higher in males than in females (22.59 ± 5.74 vs. 20.72 ± 17.4 cm, p = 0.002), as physiologically observed, and was positively related to height (p = 0.027), negatively to BMI (p = 0.001) and BA/CA ratio (p = 0.001) at NCCAH diagnosis. Gender, genotype, biochemical data, and hydrocortisone treatment did not significantly impair height outcomes of these NCCAH children. Conclusions: The results of this study suggest that AH and GT of NCCAH patients are mainly affected by the severity of phenotype (CA, BA/CA ratio, and H) at the time of diagnosis.
2020
Growth Trajectory and Adult Height in Children with Nonclassical Congenital Adrenal Hyperplasia / Wasniewska, M. G.; Morabito, L. A.; Baronio, F.; Einaudi, S.; Salerno, M.; Bizzarri, C.; Russo, G.; Chiarito, M.; Grandone, A.; Guazzarotti, L.; Spinuzza, A.; Corica, D.; Ortolano, R.; Balsamo, A.; Abrigo, E.; Baldini Ferroli, B.; Alibrandi, A.; Capalbo, D.; Aversa, T.; Faienza, M. F.. - In: HORMONE RESEARCH IN PAEDIATRICS. - ISSN 1663-2818. - 93:3(2020), pp. 173-181. [10.1159/000509548]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/828454
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 12
social impact